Kristin Bedard

From Kineta Gets $15M in New Cancer Drug Partnership with Pfizer:

Bedard is chief scientific officer, immuno-oncology and senior vice president, discovery at Kineta, a Seattle-based biotech. Image courtesy of Kineta.